Latest Product News
Actigen Receives Positive FDA Response for Rare Disease Treatment
Actigen is one step closer to conducting clinical trials in the US for a potential breakthrough in rare disease treatment, following a recent positive pre-Investigational New Drug meeting with the US Food and Drug Administration.
Vaccizone Selects Exothera for Process Development and GMP Manufacturing of its SARS-CoV-2 Vaccine
Vaccizone has selected Exothera S.A. to fast-track process development of its SARS-CoV-2 vaccine for European clinical trials.
Ubiquigent Appoints Professor Helen Walden and Professor John Davis to Scientific Advisory Board
Ubiquigent Limited has announced the expansion of its Scientific Advisory Board with the appointments of Professor Helen Walden and Professor John Davis.
Biosynth Carbosynth Expands Peptide Offering With Acquisition of Pepscan
Biosynth Carbosynth announces today the acquisition of Pepscan.
Lonza To Establish Large-Scale, Commercial Drug Product Fill & Finish Facility in Stein (CH)
Lonza today announced plans to construct a large-scale commercial drug product fill and finish facility in Stein (CH).
Lonza Appoints Maria Soler Nunez as Head of Group Operations
Lonza today announced that its Board of Directors has appointed Maria Soler Nunez as the new Head, Group Operations.
Avacta Announces Second Dose Escalation in the Phase I Clinical Study of AVA6000 Pro-Doxorubicin
Avacta Group plc announces that the first-in-human Phase I trial of AVA6000 Pro-doxorubicin will advance to the third dose cohort following a positive review of the safety data from the dosing of the second cohort.
Needle-Free Drug Delivery Platform Startup Presents New Prototype
NovaXS Biotech Corp, developers of an in-home and needle-free drug delivery platform, for the first time unveiled its new prototype of its needle-free injection therapy smart medical device.
Automation and Innovative Design of BUCHI’s New Spray Dryer Markedly Improves Spray Drying Performance
BUCHI Labortechnik has launched the Mini Spray Dryer S-300, a new generation of spray drying systems.
Voltron Therapeutics, Inc., a Lucius Partners Company, Announces Initiation of Key Preclinical Study of VTX-067 in Immuno-Oncology
Lucius Partners, LLC has reported that its portfolio company, Voltron Therapeutics, Inc., had announced the initiation of a preclinical study of its novel vaccine candidate VTX-067 in an immune-oncology model.